We, therefore, reasoned that PPM1D truncations associated with PPM1D-mutant gliomas may also exhibit the enhanced activity of the PPM1D phosphatase, targeting known substrates in the DDR and cell cycle pathways. This evidence concerns the gene PPM1D and central nervous system cancer.